Viewing StudyNCT00501020



Ignite Creation Date: 2024-05-05 @ 6:35 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00501020
Status: COMPLETED
Last Update Posted: 2017-10-09
First Post: 2007-07-12

Brief Title: Comparison of the Efficacy and Tolerability of the Addition of AVANDIA to Submaximal Doses of Metformin
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
rosiglitazone View
Type 2 Diabetes View
metformin View